Data News > Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Updates
- Several law firms are reminding investors of the pending class-action lawsuit against Applied Therapeutics, Inc. (APLT) for securities law violations.
- The lead plaintiff deadline for potential recovery under federal securities laws is February 18, 2025.
- Investors who suffered losses between January 3, 2024, and December 2, 2024, are encouraged to seek legal counsel.
- Multiple law firms, including Levi & Korsinsky and Rosen Law Firm, are offering assistance to affected investors.
- The class action lawsuit stems from securities fraud violations and investors are urged to take action before the court deadline.
Applied Therapeutics, Inc. is currently facing a Securities Fraud Class Action Lawsuit, with multiple law firms actively involved in assisting affected investors. The lead plaintiff deadline for individuals who suffered losses on their APLT investment is set for February 18, 2025.
Investors who experienced financial losses between January 3, 2024, and December 2, 2024, have the opportunity to potentially recover under federal securities laws. Various law firms, including Levi & Korsinsky and Rosen Law Firm, are reminding investors to secure legal counsel before the important deadline.
The class action lawsuit against Applied Therapeutics, Inc. is a result of alleged securities law violations during the specified Class Period. Investors are encouraged to seek further information and take action by contacting law firms like Levi & Korsinsky for assistance.
As the legal proceedings continue, shareholders with significant losses on their investments in Applied Therapeutics, Inc. have the opportunity to lead the class action lawsuit. Law firms such as Bronstein, Gewirtz & Grossman, LLC are notifying investors of the chance to participate in seeking damages for securities fraud committed by the company.
In light of the pending Securities Fraud Class Action Lawsuit against Applied Therapeutics, Inc., affected investors are advised to consult with legal representatives to discuss their rights and potential for recovery. The deadline for taking action in the lawsuit is fast approaching, and interested parties should act promptly to secure their position in the legal proceedings.
For more information:
Up/Down Rally Price Distribution Analyst Recommendations Earning Price Impact Analysis Seasonality
Applied Therapeutics, Inc. Securities Fraud Class Action Lawsuit Updates
By KlickAnalytics Data Insights | January 10, 2025 08:00PM ET
Key Points
- Several law firms are reminding investors of the pending class-action lawsuit against Applied Therapeutics, Inc. (APLT) for securities law violations.
- The lead plaintiff deadline for potential recovery under federal securities laws is February 18, 2025.
- Investors who suffered losses between January 3, 2024, and December 2, 2024, are encouraged to seek legal counsel.
- Multiple law firms, including Levi & Korsinsky and Rosen Law Firm, are offering assistance to affected investors.
- The class action lawsuit stems from securities fraud violations and investors are urged to take action before the court deadline.
Applied Therapeutics, Inc. is currently facing a Securities Fraud Class Action Lawsuit, with multiple law firms actively involved in assisting affected investors. The lead plaintiff deadline for individuals who suffered losses on their APLT investment is set for February 18, 2025.
Investors who experienced financial losses between January 3, 2024, and December 2, 2024, have the opportunity to potentially recover under federal securities laws. Various law firms, including Levi & Korsinsky and Rosen Law Firm, are reminding investors to secure legal counsel before the important deadline.
The class action lawsuit against Applied Therapeutics, Inc. is a result of alleged securities law violations during the specified Class Period. Investors are encouraged to seek further information and take action by contacting law firms like Levi & Korsinsky for assistance.
As the legal proceedings continue, shareholders with significant losses on their investments in Applied Therapeutics, Inc. have the opportunity to lead the class action lawsuit. Law firms such as Bronstein, Gewirtz & Grossman, LLC are notifying investors of the chance to participate in seeking damages for securities fraud committed by the company.
In light of the pending Securities Fraud Class Action Lawsuit against Applied Therapeutics, Inc., affected investors are advised to consult with legal representatives to discuss their rights and potential for recovery. The deadline for taking action in the lawsuit is fast approaching, and interested parties should act promptly to secure their position in the legal proceedings.
For more information:
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.